Aerovate Therapeutics
Latest round
- Series A
Last raised
- Aug 2020
Total raised
- $73M
Investors
- 6
About Aerovate Therapeutics
Founded in 2018 and based in Massachusetts, US, Aerovate Therapeutics, Inc. develops a pharmaceutical drug that helps in the treatment of pulmonary arterial hypertension. The company was founded by Dr. Benjamin T. Dake. Mr. Tim Noyes serves as the CEO of Aerovate Therapeutics, Inc. The company's product is called AV-101, an inhaled dry powder formulation of imatinib that helps in delivering the medicine to the diseased lung tissues while reducing systemic adverse effects. It provides treatment for pulmonary arterial hypertension and rare cardiopulmonary diseases. The company's revenue is generated by the sales of its therapeutic drug called AV-101 to PAH patients and other related markets. The company plans to become a publicly listed company in June 2021.
Who invested in Aerovate Therapeutics
6 investors across 2 rounds
See all investors in Aerovate Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aerovate Therapeutics
Who invested in Aerovate Therapeutics?
Aerovate Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aerovate Therapeutics raised?
Aerovate Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aerovate Therapeutics last raise money?
Aerovate Therapeutics's most recent round on record is a Series A, in Aug 2020.
What does Aerovate Therapeutics do?
Founded in 2018 and based in Massachusetts, US, Aerovate Therapeutics, Inc.
Where is Aerovate Therapeutics headquartered?
Aerovate Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Aerovate Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aerovate Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aerovate Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.